OptimizeRx Corp: Form 8-K, filed Oct 25, 2023
Filed with the SEC on Oct 25, 2023 and accepted by EDGAR at Oct 25, 2023, 20:00 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 2.01 Completion of an acquisition or disposition
- Item 3.02 Unregistered sale of equity
- Item 5.02 Departure or appointment of officers or directors
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001013762-23-006625. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.